ATYPICAL AUTOANTIGEN TARGETS OF PERINUCLEAR ANTINEUTROPHIL CYTOPLASM ANTIBODIES (P-ANCA) - SPECIFICITY AND CLINICAL ASSOCIATIONS

被引:37
|
作者
LESAVRE, P
NOEL, LH
GAYNO, S
NUSBAUM, P
REUMAUX, D
ERLINGER, S
GRUNFELD, JP
HALBWACHSMECARELLI, L
机构
[1] HOP BEAUJON, DEPT HEPATOL & GASTROENTEROL, F-92118 CLICHY, FRANCE
[2] HOP NECKER ENFANTS MALAD, INSERM, U90, F-75743 PARIS 15, FRANCE
[3] HOP BEAUJON, INSERM, U24, F-92118 CLICHY, FRANCE
[4] CTR HOSP VALENCIENNES, DEPT BIOL, F-59322 VALENCIENNES, FRANCE
关键词
D O I
10.1006/jaut.1993.1016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Atypical antineutrophil cytoplasm antibodies (A-ANCA) are defined here as ANCA detected by IIF and not directed against the predominant ANCA antigens, proteinase 3 (PR3) and myeloperoxidase (MPO). A-ANCA are found in a variety of clinical conditions, namely rheumatoid arthritis, inflammatory bowel diseases, chronic hepatic diseases and several infections including HIV infection. They are directed against a variety of still ill-defined neutrophil antigens and most frequently yield a perinuclear pattern (P-ANCA) of binding by indirect immunofluorescence on ethanol fixed neutrophils. This paper reviews the literature on A-ANCA and our recent data suggesting that, among others, cathepsin G is one of the predominant antigen targets of A-ANCA. From a clinical point of view, the distinction between MPO-ANCA and A-ANCA is not possible by indirect immunofluorescence (IIF). The determination of ANCA antigens by specific ELISA is therefore necessary to differentiate P-ANCA with MPO specificity from those with undefined specificity. This is of importance because the clinical value of MPO-ANCA is clearly established while the presence of A-ANCA is difficult to interpret given their occurrence in a large variety of clinical conditions. © 1993 Academic Press Limited.
引用
收藏
页码:185 / 195
页数:11
相关论文
共 32 条
  • [21] Clinical and prognostic significance of p-ANCA antibodies positivity in Idiopathic Pulmonary Fibrosis
    Muscato, Giuseppe
    Libra, Alessandro
    Ielo, Giuseppe
    Sciacca, Enrico
    Palmucci, Stefano
    Sambataro, Gianluca
    Vancheri, Carlo
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [22] A case of bilateral optic neuropathy and recurrent transverse myelopathy associated with perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA)
    Harada, T
    Ohashi, T
    Harada, C
    Yoshida, K
    Maguchi, S
    Moriwaka, F
    Matsuda, H
    JOURNAL OF NEURO-OPHTHALMOLOGY, 1997, 17 (04) : 254 - 256
  • [23] Environmental factors, genetic predisposition and subclinical inflammation in the development of perinuclear-antineutrophil cytoplasmic antibody (P-ANCA)-positive ulcerative colitis: A European twin study
    Bergemalm, D.
    Amcoff, K.
    Pierik, M. J.
    Colombel, J. F.
    Vermeire, S.
    Bodin, L.
    Halfvarson, J.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i787 - i787
  • [24] CLINICAL RELEVANCE OF TESTING FOR ANTINEUTROPHIL CYTOPLASM ANTIBODIES (ANCA) WITH A STANDARD INDIRECT IMMUNOFLUORESCENCE ANCA TEST IN PATIENTS WITH UPPER OR LOWER RESPIRATORY-TRACT SYMPTOMS
    DAVENPORT, A
    LOCK, RJ
    WALLINGTON, TB
    THORAX, 1994, 49 (03) : 213 - 217
  • [25] Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: Prevalence, antigen specificity, and clinical associations
    Manolova I.
    Dancheva M.
    Halacheva K.
    Rheumatology International, 2001, 20 (5) : 197 - 204
  • [26] Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations
    Manolova, I
    Dancheva, M
    Halacheva, K
    RHEUMATOLOGY INTERNATIONAL, 2001, 20 (05) : 197 - 204
  • [27] Perinuclear antineutrophil cytoplasmic antibody (p-ANCA) and anti saccharomyces cerevisiae antibody (ASCA) incidence may vary among different ethnic groups with inflammatory bowel disease (IBD)
    Basu, D
    Allu, H
    Sellin, JH
    GASTROENTEROLOGY, 2004, 126 (04) : A215 - A215
  • [28] RESET OF PERINUCLEAR ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (P-ANCA) IN PATIENT WITH SEVERE ASTHMA AND EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) DURING BENRALIZUMAB TREATMENT
    Graziani, E.
    Scarano, P.
    Petroianni, A.
    D'Antoni, L.
    Palange, P.
    CHEST, 2020, 157 (06) : 12A - 12A
  • [29] Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC)
    Sobajima, J
    Ozaki, S
    Uesugi, H
    Osakada, F
    Shirakawa, H
    Yoshida, M
    Nakao, K
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 111 (02): : 402 - 407
  • [30] Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: Non-histone chromosomal proteins, HMG1 and HMG2
    Sobajima, J
    Ozaki, S
    Osakada, F
    Uesugi, H
    Shirakawa, H
    Yoshida, M
    Nakao, K
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 (01): : 135 - 140